Accelerate to discover

Back to filter

Related topics

Genotype-targeted local therapy of glioma

Spectral Instruments Imaging

Mar 26, 2020

Lower-grade gliomas are often characterized by mutations in metabolism-related genes isocitrate dehydrogenase 1 (IDH1)...

Cytek spectral cytometers: 21 color panels with just 2 lasers

Cytek Biosciences

Mar 23, 2020

Until recently, developing multicolor fluorescence-based flow cytometry assays on a two laser system has been limited...

Cancer cells resist mechanical destruction in the circulation via RhoA-myosin II axis

Spectral Instruments Imaging

Mar 20, 2020

Tumors may generate millions of Circulating tumor cells per day, but seminal work in cancer biology has established the...

IncuCyte live cell analysis system for 3D Organoids discovery

Sartorius

Mar 18, 2020

Live-Cell Analysis has revolutionized numerous studies, with a wide selection of applications namely 3D Tumour Spheroid...

Mar 28, 2020

Webinar recording: Ex vivo microangioCT, advances in microvascular imaging

Bruker Biospin

Mar 16, 2020

A new technique called microangioCT imaging is being used with a novel polymerizing contrast agent that enables 3D...

Single Cell Sequencing sample preparation without centrifugation

Curiox

Mar 10, 2020

Single-cell genomics is rapidly growing. Nature Methods named multimodal omics the method of the year for 2019. And as...

Introducing Amnis CellStream - Ultra-high sensitivity and flexibility

Luminex

Mar 6, 2020

The new CellStream Benchtop flow cytometer delivers unparalleled sensitivity and flexibility for cell and particle...

Mar 28, 2020

Hitachi Koki - World leader for Ultracentrifuges & High-Speed Centrifuges

Hitachi Koki

Mar 3, 2020

Hitachi Koki, as a world leading producer of centrifuges offers general purpose floor standing and table top...

Show all topics (10)

In vitro hypoxia studies using xCELLigence platform

Jun 14, 2016

Hypoxia, where the body or localized regions of the body are deprived of adequate oxygen supply, occurs during numerous acute and chronic disease states. Examples include reduced blood flow during heart attack or stroke, and the oxygen-restricted microenvironment within a tumor. Though cells can be studied in vitro under similar oxygen-poor conditions using a hypoxia chamber glove box, the inefficiencies of traditional endpoint assays are exacerbated by the constraints of working inside the chamber. In contrast, an xCELLigence instrument run within a hypoxia chamber will continuously provide a real-time assessment of cell number, cell size/morphology, cell attachment quality, and cell migration/invasion without the need for intermittent manipulation/intervention by the researcher.

Key Benefits of xCELLigence:
- Data quantity: Automatic real-time data acquisition makes it possible to collect, with ease, significantly more data points than what is possible using traditional end point assays. This is especially true for hypoxia studies because manual acquisition of end points inside a hypoxia chamber is difficult and laborious.
- Data quality and reproducibility are significantly better than what is possible using end point assays.
- Time savings: Once cells are plated, data can be acquired continuously for anywhere from minutes to days/weeks without the need for hands-on time by the researcher.

All seven xCELLigence instruments are compatible with in vitro hypoxia studies.

Application
Product news

Related technologies: Real-time, label free cell analysis

Brand profile

Acea Biosciences

ACEA manufactures xCELLigence impedance-based, label-free, real time cell analysis system and NovoCyte flow cytometers.

Related products

Located inside a tissue culture incubator, the RTCA DP Analyzer has three integrated stations for E-Plates 16 or CIM-Plates 16

show detail

Located inside a tissue culture incubator, it is capable of switching any one of the wells on any of six E-Plates to the RTCA Analyzer for impedance measurement

show detail

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey